Hemab Therapeutics Holdings, Inc.(COAG:US)
Market Cap$1.329B
Key Metrics
Price$30.07
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$49.86M
Total Assets$175.26M
Net Assets-$198.62M
Total Debt$1.06M
Key Metrics
Price$30.07
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$49.86M
Total Assets$175.26M
Net Assets-$198.62M
Total Debt$1.06M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $23.61M | $16.56M | |
| Research and Development | $19.46M | $14.1M |
| Selling, General, and Administrative | $4.15M | $2.46M |
| Other Operating Expenses | - | - |
Operating Income | -$23.61M | -$16.56M |
| $937K | $1.06M | |
| Non-Operating Interest Income | $1.22M | $473K |
| Non-Operating Interest Expense | - | - |
| Other Income/Expense | -$282K | $591K |
Income Before Tax | -$22.68M | -$15.5M |
Income Tax | $12K | -$190K |
Net Income | -$22.69M | -$15.31M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$22.69M | -$15.31M |
Shares Outstanding (Basic) | 44.19M | 946K |
Shares Outstanding (Diluted) | 44.19M | 946K |
EPS (Basic) | -$0.51 | -$16.18 |
EPS (Diluted) | -$0.51 | -$16.18 |
EBIT | -$23.61M | -$16.56M |
EBITDA | -$23.54M | -$16.49M |